Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Electronic Advice Request System for Nephrology in Alberta: Pilot Results and Implementation.

Bello AK, Zaidi D, Braam B, Chou S, Courtney M, Deved V, Glassford J, Jindal K, Klarenbach S, Osman M, Scott-Douglas N, Shurraw S, Thompson S, Manns B, Hemmelgarn B, Tonelli M.

Can J Kidney Health Dis. 2019 Oct 4;6:2054358119879778. doi: 10.1177/2054358119879778. eCollection 2019.

2.

Buttonhole versus rope-ladder cannulation of arteriovenous fistulas for hemodialysis: a systematic review.

Wong B, Muneer M, Wiebe N, Storie D, Shurraw S, Pannu N, Klarenbach S, Grudzinski A, Nesrallah G, Pauly RP.

Am J Kidney Dis. 2014 Dec;64(6):918-36. doi: 10.1053/j.ajkd.2014.06.018. Epub 2014 Aug 8. Review.

PMID:
25110302
3.

Intensive glycemic control in type 2 diabetics at high cardiovascular risk: do the benefits justify the risks?

Shurraw S, Tonelli M.

Kidney Int. 2013 Mar;83(3):346-8. doi: 10.1038/ki.2012.431.

4.

Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study.

Shurraw S, Hemmelgarn B, Lin M, Majumdar SR, Klarenbach S, Manns B, Bello A, James M, Turin TC, Tonelli M; Alberta Kidney Disease Network.

Arch Intern Med. 2011 Nov 28;171(21):1920-7. doi: 10.1001/archinternmed.2011.537.

PMID:
22123800
5.

Glycemic control and the risk of death in 1,484 patients receiving maintenance hemodialysis.

Shurraw S, Majumdar SR, Thadhani R, Wiebe N, Tonelli M; Alberta Kidney Disease Network.

Am J Kidney Dis. 2010 May;55(5):875-84. doi: 10.1053/j.ajkd.2009.12.038. Epub 2010 Mar 25.

PMID:
20346561
6.

AURORA: is there a role for statin therapy in dialysis patients?

Shurraw S, Tonelli M.

Am J Kidney Dis. 2010 Feb;55(2):237-40. doi: 10.1053/j.ajkd.2009.09.018. Epub 2009 Nov 17. No abstract available.

PMID:
19926372
7.

Guidelines for the management of chronic kidney disease.

Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, Ruzicka M, Burns K, Manns B, White C, Madore F, Moist L, Klarenbach S, Barrett B, Foley R, Jindal K, Senior P, Pannu N, Shurraw S, Akbari A, Cohn A, Reslerova M, Deved V, Mendelssohn D, Nesrallah G, Kappel J, Tonelli M; Canadian Society of Nephrology.

CMAJ. 2008 Nov 18;179(11):1154-62. doi: 10.1503/cmaj.080351. Review. No abstract available.

8.

Statins for treatment of dyslipidemia in chronic kidney disease.

Shurraw S, Tonelli M.

Perit Dial Int. 2006 Sep-Oct;26(5):523-39. Review.

PMID:
16973506
9.

Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.

MacKinnon M, Shurraw S, Akbari A, Knoll GA, Jaffey J, Clark HD.

Am J Kidney Dis. 2006 Jul;48(1):8-20. Review.

PMID:
16797382
10.

Vascular access complications in daily dialysis: a systematic review of the literature.

Shurraw S, Zimmerman D.

Minerva Urol Nefrol. 2005 Sep;57(3):151-63. Review.

PMID:
15986014
11.

Frequency-dependent regulation of cardiac Na(+)/Ca(2+) exchanger.

Omelchenko A, Bouchard R, Shurraw S, Trac M, Hnatowich M, Hryshko LV.

Am J Physiol Heart Circ Physiol. 2005 Oct;289(4):H1594-603. Epub 2005 Jun 10.

12.

Inhibition of Na+/Ca2+ exchange by KB-R7943: transport mode selectivity and antiarrhythmic consequences.

Elias CL, Lukas A, Shurraw S, Scott J, Omelchenko A, Gross GJ, Hnatowich M, Hryshko LV.

Am J Physiol Heart Circ Physiol. 2001 Sep;281(3):H1334-45.

Supplemental Content

Loading ...
Support Center